IL10 and leukemia: Importantly, malignant BM-derived ST2+ Treg cells produce significantly more TGFβ and IL-10 than ST2− Treg cells (Fig. 2D, MLL-AF9 leukemia; Supplementary Fig. 7A, B, DNMT3A/FLT3ITD leukemia).